Point of Care (PoC) Diagnostics Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2028

commentaires · 2 Vues

Point of care diagnostic devices are widely used in healthcare facilities and home care settings to obtain diagnostic results of patients.

The global point of care (PoC) diagnostics size is expected to reach USD 66.72 Billion by 2028 at a CAGR of 10.70%, according to a new report by Reports and Data. Growth in market revenue is attributed to rapidly growing geriatric population, increasing prevalence of target diseases worldwide, rising burden of infectious diseases such as COVID-19, and technological advancements in point of care diagnostic devices. Extensive use of point of care diagnostics for home healthcare, surging demand for rapid and accurate diagnostic results, increasing cases of COVID-19 worldwide, and rising volumes of molecular and antibody point of care diagnostic tests are the other major factors accountable for growth of the global point of care (PoC) diagnostics market.

Point of care diagnostic devices are widely used in healthcare facilities and home care settings to obtain diagnostic results of patients. These devices provide rapid feedback on various medical tests and allow healthcare professionals to achieve accurate, lab-quality diagnostic results in real-time. The key benefits of point of care diagnostics are rapid decision-making, reduced operating times, reduced post-operative care time, increased number of outpatient clinic visits, and lesser risks of antimicrobial contamination. This type of diagnostics helps doctors better diagnose and monitor a patient’s condition and their response to treatment.

Top Companies Profiled in the Report Include:

Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Additionally, the report consists a detailed analysis of the segmentation of the Point of Care (PoC) Diagnostics market based on product types and end-use/application offered in the Point of Care (PoC) Diagnostics market.

Product Type Outlook (Revenue, USD Billion; 2020-2028)

  • Glucose Monitoring Products
    • Strips
    • Meters
    • Lancets Lancing Devices
  • Cardiometabolic Testing Products
    • Cardiac Marker Testing Products
    • Blood Gas/Electrolytes Testing Products
    • HBA1C Testing Products
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Healthcare-Associated Infection (HAI) Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease Testing Products
  • Coagulation Testing Products
  • PT/INR Testing Products
  • Activated Clotting Time (ACT/APTT) Testing Products
  • Pregnancy and Fertility Testing Products
  • Pregnancy Testing Products
  • Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Others

Platform Outlook (Revenue, USD Billion; 2020-2028)

  • Molecular Diagnostics
  • Agglutination assays
  • Biosensors
  • Dipsticks
  • Lateral Flow Assays
  • Microfluidics
  • Solid phase

Prescription Mode Outlook (Revenue, USD Billion; 2020-2028)

  • Prescription-based Testing
  • OTC Testing

End-use Outlook (Revenue, USD Billion; 2020-2028)

  • Hospitals/Critical Care Centers
  • Professional Diagnostic Centres
  • Outpatient Healthcare and Ambulatory Care Settings
  • Clinical Laboratories
  • Research Laboratories
  • Home Care
  • Others

Country-wise regional analysis covers:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.